3-氯哌啶 | 50564-59-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 3-氯哌啶
• 英文名称: 3-chloro-piperidine
• 英文别名: 3-Chlor-piperidin；3-Chloropiperidine
• CAS: 50564-59-5
• 化学式: C₅H₁₀ClN
• 分子量: 119.594
• InChiKey: YQUBWBSLSNIUBN-UHFFFAOYSA-N

物化性质

• 沸点：
  174℃
• 密度：
  1.06
• 闪点：
  59℃

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-氯哌啶 、 2-[4-(Phenylacetylamino-methyl)-phenyl]-oxazole-4-carboxylic acid 在 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 生成 N-[[4-[4-(3-chloropiperidine-1-carbonyl)-1,3-oxazol-2-yl]phenyl]methyl]-2-phenylacetamide
  参考文献：
  名称：

  Discovery and structure–activity relationship of 2-phenyl-oxazole-4-carboxamide derivatives as potent apoptosis inducers

  摘要：

  As a continuation of our efforts to discover novel apoptosis inducers as anticancer agents using a cell-based caspase HTS assay, 2-phenyl-oxazole-4-carboxamide derivatives were identified. The structure-activity relationships of this class of molecules were explored. Compound 1k, with EC50 of 270 nM and GI(50) of 229 nM in human colorectal DLD-1 cells, was selected and demonstrated the ability to cleave PARP and displayed DNA laddering, the hallmarks of apoptosis. Compound 1k showed 63% tumor growth inhibition in human colorectal DLD-1 xenograft mouse model at 50 mpk, bid. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.06.018
• 作为产物：
  描述：

  3-氯吡啶 在 sodium amalgam 作用下， 生成 3-氯哌啶
  参考文献：
  名称：

  Ciamician; Dennstedt, Gazzetta Chimica Italiana, 1881, vol. 11, p. 305

  摘要：

  DOI：

文献信息

• [EN] PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER<br/>[FR] DÉRIVÉS DE PYRIMIDINE UTILISÉS DANS LE TRAITEMENT DU CANCER
  申请人：MERCK PATENT GMBH

  公开号：WO2016128140A1

  公开（公告）日：2016-08-18

  Compounds of Formula I or II in which R1, X1 and X2 have the meanings indicated in claim 1, are MTH1 inhibitors and can be employed, inter alia, in the treatment of cancer.

  具有公式I或II的化合物，其中R1、X1和X2具有权利要求1中所示的含义，是MTH1抑制剂，可以用于治疗癌症。
• 1-Heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
  申请人：Wyeth

  公开号：US20040023970A1

  公开（公告）日：2004-02-05

  The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor. 1

  本发明提供了一种I式化合物及其用于治疗与5-HT6受体相关或受其影响的中枢神经系统疾病的用途。
• 1-HETEROCYCLYLALKYL-3-SULFONYLAZAINDOLE OR -AZAINDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
  申请人：Bernotas Ronald Charles

  公开号：US20080306106A1

  公开（公告）日：2008-12-11

  The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.

  本发明提供了一种I式化合物及其用于治疗与5-HT6受体有关或受其影响的中枢神经系统疾病的用途。
• Use of a catalyst in epoxy compositions
  申请人：THE DOW CHEMICAL COMPANY

  公开号：EP0328020A2

  公开（公告）日：1989-08-16

  Storage stable compositions are disclosed which comprise an epoxide containing compound, a phenolic hydroxyl containing compound, and a catalyst compound for catalyzing the reaction between epoxide groups and aromatic hydroxyl groups which catalyst comprises the product resulting from contacting an onium compound, non-heterocyclic amine compound, heterocyclic nitrogen compound or salt thereof with an acid or a salt of an acid having a weak nucleophilic anion.

  本发明公开了一种贮存稳定的组合物，该组合物包括一种含环氧化物的化合物、一种含酚羟基的化合物和一种催化环氧化物基团与芳香羟基基团反应的催化剂化合物，该催化剂包括鎓化合物、非杂环胺化合物、杂环氮化合物或其盐与酸或具有弱亲核阴离子的酸的盐接触后产生的产物。
• Latent catalysts, cure-inhibited epoxy resin compositions and laminates prepared therefrom
  申请人：THE DOW CHEMICAL COMPANY

  公开号：EP0458502A2

  公开（公告）日：1991-11-27

  In summary, the application is related to the discovery of a class of compounds which comprises boric acid or maleic acid or a mixture of boric acid with at least one acid having a weak nucleophilic anion, which inhibits the reaction of a polyepoxide with a curing agent at low temperatures. In another embodiment the application is a latent catalyst system adapted for curing a polyepoxide resulting from contacting I) a catalyst for the cure of a polyepoxide compound comprising an amine, heterocyclic nitrogen phosphine, sulfide, phosphine, sulfide, ammonium, phosphonium, sulfonium, arsonium, containing compound or a mixture thereof; with II) boric acid, or a mixture of boric acid with at least an acid having a weak nucleophilic anion. Further the application relates to epoxy resin compositions containing the inhibitor or latent catalytic composition. In still another embodiment the application relates to a composition useful for curing a polyepoxide which contains: A) an inhibiting amount of boric acid or maleic acid or a mixture of boric acid with at least one acid having a weak nucleophilic anion; and optionally B) a catalytic amount of a catalyst useful for accelerating the reaction of a polyepoxide with the curing agent, wherein the inhibitor and catalyst may be present in complex form.

  总之，本申请涉及一类化合物的发现，该化合物由硼酸或马来酸或硼酸与至少一种具有弱亲核阴离子的酸的混合物组成，在低温下可抑制聚环氧化物与固化剂的反应。在另一个实施方案中，本申请涉及一种潜伏催化剂系统，该系统适用于固化聚环氧乙烷，该固化聚环氧乙烷化合物的催化剂包括胺、杂环含氮膦、硫化物、膦、硫化物、铵、鏻、锍、胂、含化合物或其混合物；与 I) 硼酸或硼酸与至少一种具有弱亲核阴离子的酸的混合物接触后产生的聚环氧乙烷。此外，本申请还涉及含有抑制剂或潜在催化成分的环氧树脂组合物。在另一个实施方案中，本申请涉及一种用于固化聚环氧树脂的组合物，该组合物含有A) 抑制量的硼酸或马来酸或硼酸与至少一种具有弱亲核阴离子的酸的混合物；以及 B) 催化量的催化剂，用于加速聚环氧化物与固化剂的反应，其中抑制剂和催化剂可以复合物形式存在。